Androgens Regulate Phosphodiesterase Type 5 Expression and Functional Activity in Corpora Cavernosa
Top Cited Papers
- 1 May 2004
- journal article
- Published by The Endocrine Society in Endocrinology
- Vol. 145 (5) , 2253-2263
- https://doi.org/10.1210/en.2003-1699
Abstract
By real-time RT-PCR and Western blot analysis, we found that phosphodiesterase type 5 (PDE5) mRNA and protein abundance was several fold higher in human male than in female reproductive tracts. The highest mRNA level (>1 x 10(7) molecules/microg total RNA) was detected in human corpora cavernosa (CC), where PDE5 protein was immunolocalized in both muscular and endothelial compartment. The possible role of androgens in regulating PDE5 expression was studied using a previously established rabbit model of hypogonadotropic hypogonadism. In this model, hypogonadism reduced, and testosterone (T) supplementation restored, CC PDE5 gene and protein expression. In addition, T supplementation completely rescued and even enhanced cyclic GMP conversion to metabolites, without changing IC(50) for sildenafil (IC(50) = 2.16 +/- 0.62 nm). In control CC strips, sildenafil dose-dependently increased relaxation induced by electrical field stimulation, with EC(50) = 3.42 +/- 1.7 nm. Hypogonadism reduced, and T increased, sildenafil effect on electrical field stimulation, again without changing their relative EC(50) values. CC sensitivity to the NO-donor NCX4040 was greater in hypogonadal rabbit strips than in control or T-treated counterparts. Moreover, sildenafil enhanced NCX4040 effect in eugonadal rabbit strips but not in hypogonadal ones. This suggests that androgens up-regulate PDE5 in rabbit penis. We also measured PDE5 gene expression and metabolic activity in human CC from male-to-female transsexual individuals, chronically treated with estrogens and cyproterone acetate. Comparing the observed values vs. eugonadal controls, PDE5 mRNA, protein, and functional activity were significantly reduced. In conclusion, we demonstrated, for the first time, that androgens positively regulate PDE5, thus providing a possible explanation about the highest abundance of this enzyme in male genital tract.Keywords
This publication has 37 references indexed in Scilit:
- Cyclic Nucleotide Phosphodiesterase 5 and Sildenafil: Promises RealizedMolecular Pharmacology, 2003
- Isolation of two isoforms of phosphodiesterase 5 from rat penisInternational Journal Of Impotence Research, 2003
- Endothelium-dependency of yohimbine-induced corpus cavernosum relaxationInternational Journal Of Impotence Research, 2002
- Human PDE5A gene encodes three PDE5 isoforms from two alternate promotersInternational Journal Of Impotence Research, 2002
- Identification and Regulation of Human PDE5A Gene PromoterBiochemical and Biophysical Research Communications, 2001
- Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′-cyclic nucleotide phosphodiesteraseGene, 1998
- Molecular Cloning and Expression of Human cGMP-Binding cGMP-Specific Phosphodiesterase (PDE5)Biochemical and Biophysical Research Communications, 1998
- Androgen and Pituitary Control of Penile Nitric Oxide Synthase and Erectile Function in the Rat1Biology of Reproduction, 1996
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- The Control of Deviant Sexual Behaviour by DrugsThe British Journal of Psychiatry, 1974